← back to search

Gholamreza Bidkhori

King's College London · GB
Area of research
Molecular Biology · Physiology
Research interest
Research interests include Bioinformatics and Genomic Networks, Microbial Metabolic Engineering and Bioproduction, Gut microbiota and health, and Metabolomics and Mass Spectrometry Studies.
h-index
24
citations
5,734
works
52
NIH funding
primary concept
email

Recent publications

Transient colonizing microbes promote gut dysbiosis and functional impairment
npj Biofilms and Microbiomes 2024cited by 28position: middledoi
Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment
npj Systems Biology and Applications 2023cited by 36position: middledoi
Genome-scale metabolic modelling of the human gut microbiome reveals changes in the glyoxylate and dicarboxylate metabolism in metabolic disorders
iScience 2022cited by 56position: middledoi
Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson’s disease
Cell Reports 2021cited by 177position: middledoi
Acute kidney injury leading to CKD is associated with a persistence of metabolic dysfunction and hypertriglyceridemia
iScience 2021cited by 42position: middledoi
Compositional and functional differences of the mucosal microbiota along the intestine of healthy individuals
Scientific Reports 2020cited by 407position: middledoi
The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non‐alcoholic fatty liver disease
Molecular Systems Biology 2020cited by 51position: middledoi
Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation
American Journal of Geriatric Psychiatry 2019cited by 67position: middledoi
Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
Frontiers in Genetics 2019cited by 46position: middledoi
Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes
Proceedings of the National Academy of Sciences 2018cited by 227position: firstdoi
Understanding the Representative Gut Microbiota Dysbiosis in Metformin-Treated Type 2 Diabetes Patients Using Genome-Scale Metabolic Modeling
Frontiers in Physiology 2018cited by 83position: middledoi
Characterization of heterogeneous redox responses in hepatocellular carcinoma patients using network analysis
EBioMedicine 2018cited by 46position: middledoi
Tamoxifen-Induced Apoptosis of MCF-7 Cells via GPR30/PI3K/MAPKs Interactions: Verification by ODE Modeling and RNA Sequencing
Frontiers in Physiology 2018cited by 44position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Adil Mardinoğlu · King's College London9 papers (2018–2024)Mathias Uhlén · Science for Life Laboratory9 papers (2018–2024)Saeed Shoaie · King's College London8 papers (2018–2024)Sunjae Lee · King's College London7 papers (2018–2024)Rui Benfeitas · Science for Life Laboratory4 papers (2018–2020)Cheng Zhang · Zhejiang International Studies University4 papers (2018–2020)Jens Nielsen · EduInnovation4 papers (2018–2020)Jan Borén · Sahlgrenska University Hospital3 papers (2018–2020)Gordon Proctor · King's College London3 papers (2020–2024)Dorinês Rosário · King's College London3 papers (2018–2023)David L. Moyes · King's College London2 papers (2022–2024)Doheon Lee · Science for Life Laboratory2 papers (2020–2024) · 2 papers (2020–2024)S. Dusko Ehrlich · Queen Mary University of London2 papers (2020–2021)Abdellah Tebani · Science for Life Laboratory2 papers (2020–2022)Muhammad Arif · Science for Life Laboratory2 papers (2018–2020)Lars Engstrand · Karolinska Institutet2 papers (2020–2024) · 2 papers (2018–2018)Milad Rouhimoghadam · University of Iowa1 papers (2018–2018)Martin Adiels · Sahlgrenska University Hospital1 papers (2020–2020)